HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Mastin, S. T. Articles by Quesenberry, L. Search for Related Content PubMed PubMed Citation Articles by Mastin, S. T. Articles by Quesenberry, L.

FDG SPECT in Patients With Lung Masses^*

^* From the Departments of Radiology (Drs. Mastin and Drane) and Pulmonology (Drs. Harman and Fenton), University of Florida College of Medicine, and the Gainesville Veterans Administration Hospital (Mr. Quesenberry), Gainesville, FL.

Study objectives: To determine whether 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) single-photon emission CT (SPECT) is useful in characterizing pulmonary masses.

Design: Scans were prospectively acquired and interpreted. Interpretations were performed with CT or chest radiograph but interpreters were blinded to eventual diagnosis.

Setting: University hospital practice and affiliated Veterans Administration medical center.

Patients or participants: Forty patients participated as part of an institutional review board–approved research protocol, and informed consent was obtained in all. Eight additional patient scans were acquired as part of their clinical evaluation for pulmonary mass.

Measurements and results: There were 26 malignant lesions (12 were 1 to 2 cm in size, the rest were larger) and 17 benign lesions (3 were < 1 cm in size, 9 were 1 to 2 cm in size, and 5 were larger). Averaged sensitivity, specificity, positive predictive value, and negative predictive value were, respectively, 50% (12 of 24), 94% (17 of 18), 92% (12 of 13), and 59% (17 of 29) for lesions 1 to 2 cm in size, 100% (28 of 28), 90% (9 of 10), 97% (28 of 29), and 100% (9 of 9) for lesions > 2 cm in size. There was good correlation between readers (p < 0.0001).

Conclusion: FDG SPECT is useful in characterizing pulmonary masses > 2 cm in size and appears to be equivalent to positron emission tomography for these lesions. Although currently clinically suboptimal for characterizing lesions 2 cm in size, FDG SPECT appears to be better than current anatomic imaging methods. In addition, the positive predictive value of FDG SPECT for small lesions is also high (92%), and this technique appears potentially useful in the subset of patients in whom a positive result would alter clinical diagnostic pathways or care.

Key Words: emission CT • lung neoplasms • lung nodule • radionuclide studies

This article has been cited by other articles:

				J. F. Schaefer, J. Vollmar, F. Schick, R. Vonthein, M. D. Seemann, H. Aebert, R. Dierkesmann, G. Friedel, and C. D. Claussen Solitary Pulmonary Nodules: Dynamic Contrast-enhanced MR Imaging--Perfusion Differences in Malignant and Benign Lesions Radiology, August 1, 2004; 232(2): 544 - 553. [Abstract] [Full Text] [PDF]

				K. Murthy, M. Aznar, C. J. Thompson, A. Loutfi, R. Lisbona, and J. H. Gagnon Results of Preliminary Clinical Trials of the Positron Emission Mammography System PEM-I: A Dedicated Breast Imaging System Producing Glucose Metabolic Images Using FDG J. Nucl. Med., November 1, 2000; 41(11): 1851 - 1858. [Abstract] [Full Text] [PDF]